Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2017

Dec 12, 2017

35086_dirs_2017-12-12_35260dec-19c8-47e3-9e33-25cbdeec593d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-12-10

Reporting Person: DOYLE WILLIAM F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-10 Option Grant (Right to Buy) $5.70 A 40000 Acquired 2027-12-10 Common Stock (40000) Direct

Footnotes

F1: The shares subject to this option will vest in equal monthly installments commencing on the date one month following December 10, 2017, subject to the continued service of the Reporting Person as a non-employee director as of such vesting date.